Home » Vote of Confidence for Gene Therapy: $35 Million for Genetix Pharmaceuticals
Vote of Confidence for Gene Therapy: $35 Million for Genetix Pharmaceuticals
Genetix Pharmaceuticals, Inc., one of the leading companies in gene therapy, has secured $35 million in series B funding from investors Third Rock Ventures
and Genezyme Joint Ventures.
BNET
BNET
Upcoming Events
-
02May
-
07May
-
14May
-
23May
-
30May